All Product Lines Sample Clauses

All Product Lines. Semi exclusive rights during the term of this Agreement, allowing LICENSEE the ability to launch the Product Lines to the Jamaican Territory including direct to consumer via the internet to residents of Jamaica. Semi-exclusive under this Agreement means that LICENSOR will not grant a license to utilize the Technology within the Jamaican Territory to any third party other than LICENSEE, and LICENSEE’s named Partner if so named as provided in Section 1(a), under this Agreement. LICENSEE shall generate a minimum of two million United States dollars (US $2,000,000) per year in gross sales (the “Jamaican Volume Minimum”), beginning the third year of this Agreement. In the event that LICENSEE fails to meet the Jamaican Volume Minimum in any year, beginning the third year of this Agreement, LICENSOR will have the option, exercisable by written notice to LICENSEE, to grant a license to utilize the Technology in the Jamaican Territory to a maximum of two (2) additional third parties. LICENSOR retains its own rights to utilize the Technology for its own products within the Jamaican Territory.
AutoNDA by SimpleDocs
All Product Lines. Semi exclusive rights during the term of this Agreement, allowing LICENSEE the ability to launch the Product Lines to the USA Territory in properly licensed medical marijuana dispensaries, retail marijuana stores, Retailers, subject to the provisions listed above in the Recitals, and marijuana delivery services that are in compliance with all local and state licensing requirements applicable to the marijuana industry, and direct to consumer sales via internet within any state of the USA to residents of USA. Semi-exclusive under this Agreement means that LICENSOR will not permit more than four (4) such national licenses at any time for the Product Lines utilizing its Technology to be granted within the Territory, but excluding additional state licenses, including the license granted to LICENSEE, and its named Partner if so named as provided in Section 1(a), under this Agreement.
All Product Lines. Semi exclusive rights during the term of this Agreement, allowing LICENSEE the ability to launch the Product Lines to the Canada Territory by any distribution method that is in compliance with all applicable local and federal licensing requirements and direct to consumer sales via internet to residents of Canada. Semi-exclusive under this Agreement means that LICENSOR will not permit more than four (4) such national licenses at any time for the Product Lines utilizing its Technology to be granted within the Territory, but excluding additional province licenses, including the license granted to LICENSEE, and its named Partner if so named as provided in Section 1(a), under this Agreement.

Related to All Product Lines

  • Product The term “

  • Products 1.1. The information (including but not limited to the quantity, rated hashrate, unit price (“Unit Price”), total price for one item (“Total Price (One Item)”), total price for all the items (“Total Purchase Price”) of Products to be purchased by Party B from Party A is as follows (“Products”):

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Other Products After clinical or other evidence, provided in writing [***] to Company, demonstrating the practicality of a particular market or use within the LICENSED FIELD which is not being developed or commercialized by Company, Company shall either provide JHU with a reasonable development plan and start development or attempt to reasonably sublicense the particular market or use to a third party. If within six (6) months of such notification [***] Company has not initiated such development efforts or sublicensed that particular market or use, JHU may terminate this license for such particular market or use. This Paragraph shall not be applicable if Company reasonably demonstrates to JHU that commercializing such LICENSED PRODUCT(S) or LICENSED SERVICE(S) or granting such a sublicense in said market or use would have a potentially adverse commercial effect upon marketing or sales of the LICENSED PRODUCT(S) developed and being sold by Company.

  • Company Products Schedule 2.10(d) of the Company Disclosure Letter lists all Company Products, and for each such product or feature (and each version thereof) identifying its release date.

  • Manufacture of Products All Products marketed through Grantor's Web ------------------------- Site shall be manufactured, packaged, prepared, and shipped in accordance with the specifications and requirements described on Exhibit A hereto as it may be modified from time to time. Quality control standards relating to the Product's weight, color, consistency, micro-biological content, labeling and packaging are also set forth on Exhibit A. In the event that Exhibit A is incomplete, Products shall be manufactured and shipped in accordance with industry standards.

  • Defective Products None of the Group Companies has manufactured, sold or supplied products which are, or were, in any material respect, faulty or defective, or which do not comply in any material respect with any representations or warranties expressly made by such Group Company, or with all applicable regulations, standards and requirements.

  • Additional Products Throughout the Term, Rockwell shall provide to DaVita and the DaVita Facilities the right to purchase and/or lease all current or new products manufactured, utilized, licensed, sold or distributed by Rockwell or any of its Affiliates (including products and product lines acquired by Rockwell or any of its Affiliates as a result of an acquisition, merger or other transaction involving Rockwell or any of its Affiliates) that are or that become Commercially Available and which are not already covered by this Agreement or by any other agreement, whether written or oral, between the parties hereto (such products are collectively referred to as “Additional Products” and individually as an “Additional Product”). Rockwell agrees to include DaVita in all of its and its Affiliates distributions of customer announcements regarding Rockwell’s or its Affiliates’ Additional Products. The purchase price for any such Additional Products shall be negotiated by the parties hereto in good faith and the agreed upon purchase price shall be memorialized in writing as a supplement or amendment to this Agreement. Rockwell covenants and agrees that it shall only make an offer for the sale of any Additional Product(s) to DaVita’s Vice-President of Clinical Operations, Chief Medical Officer, or Vice-President of Purchasing, and not to any DaVita Facility directly; provided that the purchase of any Additional Product by DaVita or any DaVita Facility through a Rockwell product catalog made generally available to the dialysis community shall not be a breach by Rockwell of this Section 8.1. If Rockwell or any of its Affiliates acquires any Additional Product(s) as a result of an acquisition, merger or other transaction involving Rockwell or any of its Affiliates with a Person with which DaVita or a DaVita Facility, as applicable, already has a purchase or rebate arrangement whether written or oral (a “Prior Agreement”), Rockwell or such Affiliate covenants and agrees that it shall continue to abide by all of the terms and conditions of such Prior Agreement or if DaVita requests, such Additional Product(s) shall be included in this Agreement on terms to be negotiated and determined by the parties hereto as provided in this Section 8.1.

  • Product Warranty; Product Liability (a) Except as set forth on Company Disclosure Schedule 4.23, the products produced, sold or delivered by the Company in conducting the Business have been in all material respects in conformity with all product specifications and all applicable Laws. To the Company’s Knowledge, the Company has no material Liability for damages in connection therewith or any other customer or product obligations not reserved against on the Balance Sheet.

  • Manufacture of Product Prior to commercialization of the Product, the Parties may, if appropriate for both parties, negotiate in good faith a manufacturing and supply agreement to provide for Licensor to fulfill the manufacturing requirements of Licensee for Product for sale in the European market. The cost of such manufacturing shall not be greater than * percent (*%) of the cost of any competitor cGMP contract manufacturing facility that proposes to manufacturer the Product for Licensee. * Confidential information has been omitted and filed confidentially with the Securities and Exchange Commission.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!